Author(s):
Surbhi C. Gupta, Yashasvi V. Patil, Lalit R. Sargar, Snehal B. Panhalkar, Pratiksha D. Sonawane, Shivraj V. Mane
Email(s):
surbhigupta224@gmail.com
DOI:
10.52711/0974-360X.2025.00283 
Address:
Surbhi C. Gupta1*, Yashasvi V. Patil1, Lalit R. Sargar2, Snehal B. Panhalkar3, Pratiksha D. Sonawane2, Shivraj V. Mane3
1Department of Pharmaceutics, PES Modern College of Pharmacy, Nigdi, Pune, Maharashtra, India.
2Department of Quality Assurance Technique, GES Satara College of Pharmacy, Satara, Maharashtra, India.
3Department of Pharmaceutics, PES Modern College of Pharmacy, Nigdi, Pune, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 5,
Year - 2025
ABSTRACT:
The goal of the current study was to create and assess a nanosuspension of diclofenac sodium utilising a precipitation, acid-base neutralization process, and several polymers to improve the drug's solubility and bioavailability. The nanosuspension formulation was clear, and further shaking revealed no sedimentation. The solubility of Diclofenac sodium in the nanosuspension formulations is greatest in methanol. All preformulation parameters were assessed, including the qualitative and pH-dependent solubility of the drug in various pH buffer solutions, as well as the organoleptic characterization of the drug sample, melting point, pH, identification of the drug samples using UV spectroscopy, and preparation of calibration curves. The objective of the present research work was to formulate and evaluate diclofenac sodium. The viscosity of the dispersion medium was more in formulation with HPMC than the other formulations with methyl cellulose. The particle size distribution of the nanosuspension was found to be good for HPMC stabilizer as compare to methyl cellulose. From this study it was concluded that Nanosuspension consist of HPMC as stabilizer showed better result as compare to nanosuspension consist of methyl cellulose as stabilizer.
Cite this article:
Surbhi C. Gupta, Yashasvi V. Patil, Lalit R. Sargar, Snehal B. Panhalkar, Pratiksha D. Sonawane, Shivraj V. Mane. Formulation and Evaluation of Diclofenac Sodium Nanosuspension. Research Journal of Pharmacy and Technology. 2025;18(5):11983-8. doi: 10.52711/0974-360X.2025.00283
Cite(Electronic):
Surbhi C. Gupta, Yashasvi V. Patil, Lalit R. Sargar, Snehal B. Panhalkar, Pratiksha D. Sonawane, Shivraj V. Mane. Formulation and Evaluation of Diclofenac Sodium Nanosuspension. Research Journal of Pharmacy and Technology. 2025;18(5):11983-8. doi: 10.52711/0974-360X.2025.00283 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-5-6
REFERENCES:
1. Chien YW. Novel drug delivery systems. Marcel Dekker Inc. 1992, 2nd Ed, page no: 139-197.
2. Sarika V. Khandbahale. A Review- Nanosuspension Technology in Drug Delivery System. Asian J. Pharm. Res. 2019; 9(2): 130-138. doi: 10.5958/2231-5691.2019.00021.2
3. M. Kranthi Kumar Reddy, B. Narasimha Rao, K. Ravindra Reddy. Study on Effect of Excipients in Enhancing the Solubility of Nateglinide by Solid Dispersions. Asian J. Pharm. Res. 2012; 2(4): 144-147.
4. B.A. Bhairav, J.K. Bachhav, R.B. Saudagar. Review on Solubility Enhancement Techniques. Asian J. Pharm. Res. 2016; 6(3): 147-152. doi: 10.5958/2231-5691.2016.00025.3
5. Ashitosh Rohom, S.D. Mankar. Microwave Generated Nanocomposites for Solubility Enhancement. Asian Journal of Pharmaceutical Research. 2023; 13(4): 281-6. doi: 10.52711/2231-5691.2023.00051
6. Rajashri R. Kulkarni, Dipti G. Phadtare, Ravindra B. Saudagar. A Novel Approach Towards Nanosuspension. Asian J. Pharm. Res. 2015; 5(4): 186-194. doi: 10.5958/2231-5691.2015.00029.5
7. Ashok A. Hajare, Vrushali A. Patil. Formulation and Characterization of Metformin Hydrochloride Floating Tablets. Asian J. Pharm. Res. 2012; 2(3):111-117.
8. Neelam Seedher, Sonu Bhatia. Solubility enhancement of COX-2 inhibitors using various solvent systems. AAPS Pharm SciTech 2003; 4(3): 1-8. doi:10.1208/pt040333
9. Vikram M. Pandya, Jayvadan K.Patel and Dhaval J. Patel. Formulation, Optimization and Characterization of Simvastatin nanosuspension prepared by nanoprecipitation techniques. Scholar Research Library. 2011; 3(2): 129-140
10. Jacobs C, Kayser O, Müller RH. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm. 2000; 196(2): 161-4. doi: 10.1016/s0378-5173(99)00412-3
11. Niraj Kale, Ketaki Shinde, Sonam Bendre, Suhit Gilda. Particle Engineering for Customized Drug Particles and its Applications. Asian Journal of Pharmaceutical Research. 2022; 12(4): 349-8. doi: 10.52711/2231-5691.2022.00055
12. M Kakrana; NG Sahooa; L Lia; Z Judeh; Y Wang; K Chong; L Loh; Int J Pharma. 2010; 383: 285–292.
13. Gupta SC, and Phatak AA. Formulation and evaluation of a phytoconstituent in to a tablet dosage form. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2023; 14(4): 1-24. https://doi.org/10.33887/rjpbcs/2023.14.4.2
14. Liversidge G. G., Conzentino P. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int. J. Pharm. 1995; 125(2): 309–313. doi:http://dx.doi.org/10.1016/0378-5173(95)00148-C.
15. Sharma P, Denny WA, Garg S; Effect of wet milling process on the solid state of indomethacin and simvastatin; Int J Pharm. 2009; 380: 40–48. doi: 10.1016/j.ijpharm.2009.06.029.
16. Trotta M, Gallarate M, Carlotti ME, Morel S. Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. Int J Pharm. 2003; 254: 235–42. doi: 10.1016/s0378-5173(03)00029-2
17. B Singh, S Chakkal, N Ahuja.Formulation and optimization of controlled release mucoadhesive tablets of Atenolol using response surface methodology. AAPS PharmSciTech. 2006; 7(1): 19-28. doi: 10.1208/pt070103
18. Wilkinson J. Nanotechnology applications in medicine. Med, Device Technology. 2003; 14(5): 29-31. PMID: 12852120.
19. Burri, Regula and Bellucci, Sergio. Public Perception of Nanotechnology. Journal of Nanoparticle Research. 2007; 10(3): 387-391. doi:10.1007/s11051-007-9286-7.
20. Roco, M.C., Bainbridge, W. Societal implications of nanoscience and nanotechnology: Maximizing human benefit. Journal of Nanoparticle Research. 2005; 7(1): 1–13. doi:10.1007/s11051-004-2336-5.
21. Jagdale DM, Kamble VA and Kadam, VJ. Nanosuspension a novel drug delivery system. International Journal of Pharma and Bio Sciences. 2010; 1(4): 352- 360.
22. Patel M, Shah A and Dr. Patel KR. Nanosuspension: A novel approach for drug delivery system. JPSBR. 1(1): 1-10
23. Patravale, Vandana, Date Abhijit and Kulkarni. R. Nanosuspensions: A promising drug delivery strategy. The Journal of Pharmacy and Pharmacology. 2004: 827-840. doi: 10.1211/0022357023691
24. Elaine, M; Liversidge, Gary G and Liversidge, M. Drug nanoparticles formulating poorly water-soluble compounds. Toxicologic Pathology. 2008; 36: 43-48. doi: 10.1177/0192623307310946
25. AK and Venkatesha, T et. al. Nanosuspensions Ideal approach for the drug delivery of poorly water-soluble drug. Der Pharmacia Lettre. 2011; 3(2): 203-213.
26. Chingunpituk, J. Nanosuspension technology for drug delivery. Walailak J Sciand Tech. 2007; 4(2): 139-153.
27. Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM. Diclofenac nanosuspensions: Influence of preparation procedure and crystal form on drug dissolution behavior. Int J Pharm. 2009; May; 373(1- 2): 124-32. doi: 10.1016/j.ijpharm.2009.01.024
28. Jacobs C, Kayser O, Mullar RH. Production and characteristion of mucoadhesive nanosuspensions for the formulation of Bupravaquone. Int J Pharm. 2001 Feb; 214(1-2): 3-7. doi: 10.1016/s0378-5173(00)00622-0
29. K Peters, S Leitzke, JE Diederichs, K Borner, H Hahn, RH Muller, S Ehlers. Preparation of a clofazamine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J Antimicrob Chemother. 2000; 45: 77-83. doi: 10.1093/jac/45.1.77
30. Ali HS, York P, Blagden N. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation using microfluidic reactor. Int J Pharm. 2009; 375(1-2): 107-113. doi: 10.1016/j.ijpharm.2009.03.029
31. Dolenc A, Kristl J, Baumgartner S, Planinsek O. Advantages of celecoxib nanosuspension formulation and transformation in to tablets. Int J Pharm. 2009; 376(1-2): 204-212. doi: 10.1016/j.ijpharm.2009.04.038
32. Agnihotri SM, Vavia PR. Diclofenac-loaded biopolymer nanosuspensions for ophthalmic application. Nanomedicine. 2009; 5(1): 90-95. doi: 10.1016/j.nano.2008.07.003
33. Pu Xiaohui, Sun Jin, Li Mo and He Zhonggui. Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs. Current Nanoscience. 2009; 5(4): 17-27. doi:10.2174/157341309789378177
34. Shajahan Abdul, Mangesh E Bhad, Anil V Chandewar, Jayesh M Jain, Sunil B Jaiswal. Formulation of Diclofenac Sodium Delayed-Release Disintegrating Tablets. Research J. Pharma. Dosage Forms and Tech. 2010; 2(1): 77-89.
35. Kumar, MS; Mahadevan, N and Rawat, N. Solubilityμ Particle size reduction is a promising approach to improve the bioavailability of lipophilic drugs. International Journal of Recent Advances in Pharmaceutical Research. 2011: 8-18.
36. Snehal S Manekar, Ravindra L. Bakal, Manoj S. Charde. Enhancement of Dissolution profile of poorly water soluble drug using Water Soluble Carriers. Asian Journal of Pharmaceutical Research. 2022; 12(2): 137-2. doi: 10.52711/2231-5691.2022.00021
37. Thakkar PH, Vishnubhai P, Thakkar S. Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement. J. Pharm. Bioallied. Sci. 2011; 3(3): 426–34. doi: 10.4103/0975-7406.84459
38. Indian Pharmacopoeia, 1996: P - Z, Reference spectra and Appendices, Volume 2, Page no:165.
39. Zhang D, Tan T, Gao L, Zhao W, Wang P. Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies.Drug Dev Ind Pharm. 2007; 33(5): 569-75. doi: 10.1080/03639040600975147
40. Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. Int J Pharm. 2009; 373(1-2): 124-32. doi: 10.1016/j.ijpharm.2009.01.024
41. Nehal Daebis, Ossama Y Abdallah, Magda El-Massik, and Hamdy Abdelkader. Formulation and Characterization of Itraconazole Oral Nanosuspension: Methyl Cellulose as Promising Stabilizer. Journal of Drug Development and Clinical Trials. 2015; 1(1): 102-110.